Results 191 to 200 of about 51,268 (235)
The pharmacology underlying the unique antipsychotic efficacy of clozapine. [PDF]
Reynolds GP.
europepmc +1 more source
Modulation of Master Transcription Factor Expression of Nile Tilapia Leukocytes via Cholinergic Pathways. [PDF]
Girón-Pérez MI +8 more
europepmc +1 more source
Muscarinic Antagonist Antidepressants Lacking Cognitive Deficits
Chad Johnson +3 more
openaire +1 more source
Cardiovascular Outcomes Among Patients with COPD Prescribed with LABA or LAMA: A Real-World Territory Wide Study. [PDF]
Wong CK +8 more
europepmc +1 more source
Exploring Adjunctive Novel Therapeutic Approach of KarXT (Xanomeline-Trospium Chloride) for Managing Psychotic Symptoms in Patients With Schizophrenia and Alzheimer's Disease. [PDF]
Kanwal A +7 more
europepmc +1 more source
From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia? [PDF]
Golden JC, Murphy KS, Tampi RR.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Selective muscarinic receptor antagonists
Trends in Pharmacological Sciences, 1984to ex- plain the anomalous binding of cholin- ergic agonists to brain receptors~ were later demonstrated with the seEective muscarinic antagonist, pirenzepine 2. Interestingly, the search for selective antagonists, which usually follows the acceptance of a concept, antedated by many years the notion of heterogeneity of rmecarinic receptors. Intuitively
R. Hammer, A. Giachetti
openaire +3 more sources

